Highly stable molybdenum dioxide nanoparticles with strong plasmon resonance are promising in photothermal cancer therapy.
Photothermal therapy (PTT) is one of promising cancer therapy with high efficiency and minimal invasiveness. Exploiting of perfect PTT agent is vital to improve the therapy. In this study, a new type of bow tie-like molybdenum dioxide (MoO2) nanoparticles was successfully synthesized. These nanobow-ties had strong localized surface plasmon resonance (SPR) effect from visible to near infrared regions, and exhibited ultrahigh chemical stability. They could not only withstand high temperature heating without oxidation, but also resist the corrosion of strong acid and alkali. Meanwhile, the MoO2 nanoparticles were highly stable in protein-containing biological medium, though they partly degraded in PBS solution. Both in vivo and in vitro experiments indicated that they exhibited inappreciable toxicity. Under illumination of near infrared laser, they showed excellent PTT effect, as revealed by significant inhibition of cancer cell viability in vitro and efficient destruction in tumor tissue growth in vivo. These MoO2 nanoparticles possessed highly chemical stability and low toxicity with high PTT efficiency, thus promising them high potential as nanoagent in cancer treatment.